Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes

Recombinant immunotoxins (RITs) are antibody-based therapeutics that carry a toxin payload. The RG7787 RIT targets the cancer antigen mesothelin to deliver a recombinantly-engineered, reduced immunogenicity variant of Pseudomonas exotoxin A (PE) to the cytosol where it inhibits protein synthesis. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolyvas, Emily, Rudloff, Michael, Poruchynsky, Marianne, Landsman, Rebekah, Hollevoet, Kevin, Venzon, David, Alewine, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354724/
https://www.ncbi.nlm.nih.gov/pubmed/27999204
http://dx.doi.org/10.18632/oncotarget.13984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354724/
https://www.ncbi.nlm.nih.gov/pubmed/27999204
http://dx.doi.org/10.18632/oncotarget.13984

Ejemplares similares